Ajou University repository

Pharmaceutics
ISSN
  • E1999-4923
Publisher

Multidisciplinary Digital Publishing Institute (MDPI)

Listed on
(Coverage)

JCR2017-2023

SJR2011-2020;2022-2023

CiteScore2011-2023

SCIE2017-2024

SCOPUS2017-2024

DOAJ2017-2024

EMBASE2016-2024

OA Info.
OA oa mark

based on the information

  • 2017;2018;2019;2020;2021;2022;2023;2024;2025;
Keywords pharmacokinetics
Review Process Anonymous peer review
Journal info.
pages
Licences CC BY
Copyrights Yes
DOAJ Coverage Added on Date : 2010-05-05T16:28:54Z
Subject(s) Medicine: Pharmacy and materia medica
Active
Active

based on the information

  • SCOPUS:2024-10
Country
SWITZERLAND
Aime & Scopes
Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. It publishes reviews, regular research papers, communications, opinions, commentaries, and short notes. Covered topics include pharmaceutical formulation, process development, drug delivery, pharmacokinetics, biopharmaceutics, pharmacogenetics, and interdisciplinary research involving, but not limited to, engineering, biomedical sciences, and cell biology. Our aim is to encourage scientists to publish their experimental results and theoretical assumptions in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. In addition, this journal presents the following unique features: /// Manuscripts regarding research proposals and research ideas will be particularly welcomed /// Computed data or files regarding the full details of the experimental procedures can be deposited as supplementary material if it is not possible to published them in the Material and Methods section, as usual /// We also accept manuscripts addressed to a broader audience, regarding research projects financed by public funds
Article List

Showing results 21 to 31 of 31

Therapeutic interventions into innate immune diseases by means of Aptamersoa mark
  • Yasmeen, Farzana;
  • Seo, Hana;
  • Javaid, Nasir;
  • Kim, Moon Suk;
  • Choi, Sangdun
  • 2020-10-01
  • Pharmaceutics, Vol.12 No.10, pp.1-30
  • MDPI AG
Combinatorial inhibition of cell surface receptors using dual aptamer-functionalized nanoconstructs for cancer treatmentoa mark
  • Lee, Hyojin;
  • Kim, Tae Hee;
  • Park, Daechan;
  • Jang, Mihue;
  • Chung, Justin J.;
  • Kim, Soo Hyun;
  • Kim, Sang Heon;
  • Lee, Kwan Hyi;
  • Jung, Youngmee;
  • Oh, Seung Ja
  • 2020-07-01
  • Pharmaceutics, Vol.12 No.7, pp.1-18
  • MDPI AG
Shear stress‐dependent targeting efficiency using self‐assembled gelatin–oleic nanoparticles in a biomimetic microfluidic systemoa mark
  • Kang, Taehee;
  • Park, Chulhun;
  • Meghani, Nileshkumar;
  • Tran, Thao T.D.;
  • Tran, Phuong H.L.;
  • Lee, Beom Jin
  • 2020-06-01
  • Pharmaceutics, Vol.12 No.6, pp.1-15
  • MDPI AG
Topical delivery of coenzyme Q10-loaded microemulsion for skin regenerationoa mark
  • Ryu, Kyeong A.;
  • Park, Phil June;
  • Kim, Seong Bo;
  • Bin, Bum Ho;
  • Jang, Dong Jin;
  • Kim, Sung Tae
  • 2020-04-01
  • Pharmaceutics, Vol.12 No.4
  • MDPI AG
An injectable click-crosslinked hydrogel that prolongs dexamethasone release from dexamethasone-loaded microspheresoa mark
  • Heo, Ji Yeon;
  • Noh, Jung Hyun;
  • Park, Seung Hun;
  • Ji, Yun Bae;
  • Ju, Hyeon Jin;
  • Kim, Da Yeon;
  • Lee, Bong;
  • Kim, Moon Suk
  • 2019-09-01
  • Pharmaceutics, Vol.11 No.9
  • MDPI AG
Investigation of crystallization and salt formation of poorly water-soluble telmisartan for enhanced solubilityoa mark
  • Park, Chulhun;
  • Meghani, Nileshkumar M.;
  • Shin, Yongkwan;
  • Oh, Euichaul;
  • Park, Jun Bom;
  • Cui, Jing Hao;
  • Cao, Qing Ri;
  • Tran, Thao Truong Dinh;
  • Tran, Phuong Ha Lien;
  • Lee, Beom Jin
  • 2019-03-01
  • Pharmaceutics, Vol.11 No.3
  • MDPI AG
1 2